CTT Pharmaceutical Holdings CEO Ryan Khouri acquires 1,800 common shares for $111.6
CTTH•CEO buys additional CTT Pharmaceutical Holdings shares
- CTT Pharmaceutical Holdings CEO Ryan Khouri bought 1,800 CTTH shares at $0.06 each, raising direct holdings to 9.36 million shares.
